Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized for its global prevalence and potential progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH). The ...

Lay summary NAFLD may affect and progress in both obese and lean individuals ... Supporting previous reports that both NAFL and NASH have the capacity to progress,22 baseline NASH status was not ...

A careful comparison of published metabolomic data (faeces, serum, plasma, urine or liver) from healthy individuals versus those with NAFL or NASH is provided in the online supplementary tables 1–4.

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the ...

Formerly known as nonalcoholic steatohepatitis (NASH), MASH describes a type of ... Unlike some other types of fatty liver disease, MASH does not relate to alcohol use. However, promptly treating ...

Non-communicable diseases represent the primary cause of mortality and morbidity globally, accounting for 74% of all deaths and more than three-quarters of years lived with disability. Here, we ...

The Brihanmumbai Municipal Corporation (BMC) launched the first ‘Nash Clinic’ at KEM Hospital on the occasion to fight advanced form of non-alcoholic fatty liver disease Actor Amitabh Bachchan ...

It is the progressive form of non-alcoholic fatty liver disease (NAFLD). NASH can lead to cirrhosis and liver cancer. In individuals with obesity and compensated metabolic dysfunction-associated ...